2m 2m 2m 2m 2m 2m 2m
PROKIDNEY-A (PROK)
NASDAQ
$1.78-$0.04 (-2.42%)
Price as of Jun 23, 2026 6:54 PM EDT- $373.5MMarket Cap
- 200.33%1-Year Change
- BiotechnologyIndustry
PROKIDNEY-A (PROK)
$1.78-$0.04 (-2.42%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 893,000 +1,075.00% | 76,000 N/A | N/A N/A | N/A N/A | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 893,000 +1,075.00% | 76,000 N/A | 0 N/A | 0 N/A | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -114.1M -10.61% | -127.7M +19.64% | -106.7M +30.02% | -82.1M N/A | |
Depreciation and Amortization Expense | 6.6M +21.04% | 5.4M +40.98% | 3.9M +26.91% | 3.0M N/A | |
Total Operating Expenses | 165.9M -9.72% | 183.8M +21.27% | 151.5M -0.97% | 153.0M +6,458.51% | |
Operating Profit | -165.0M -10.16% | -183.7M +21.22% | -151.5M -0.97% | -153.0M +6,458.51% | |
Interest Income | 13.8M -30.07% | 19.8M -10.56% | 22.1M +269.10% | 6.0M +71,776.50% | |
Interest Expense | -4,000 -55.56% | -9,000 -25.00% | -12,000 -94.42% | -215,000 N/A | |
Interest Income and Expense and Net | 13.8M -30.06% | 19.7M -10.55% | 22.1M +282.65% | 5.8M +69,193.61% | |
Total Nonoperating Income and Expense | 4,000 -55.56% | 9,000 -25.00% | 12,000 -94.42% | 215,000 N/A | |
Income before Taxes | -151.2M -7.77% | -163.9M +26.64% | -129.5M -12.08% | -147.2M +6,211.27% | |
Income Taxes | 414,000 +169.23% | -598,000 -109.97% | 6.0M +569.20% | 896,000 N/A | |
Extraordinary Items | 318,000 -94.03% | 5.3M N/A | N/A N/A | N/A N/A | |
Net Income | -69.0M +12.75% | -61.2M +72.51% | -35.5M -76.06% | -148.1M +6,272.41% | |
Net Income from Continuing Operations Applicable to Common | -151.2M -7.77% | -163.9M +26.64% | -129.5M -12.08% | -147.2M +6,233.87% | |
Basic EPS and Net Income | -0.52 -16.13% | -0.62 +8.77% | -0.57 +147.83% | -0.23 +4.55% | |
Diluted EPS and Net Income | -0.52 -16.13% | -0.62 +8.77% | -0.57 +147.83% | -0.23 +4.55% | |
Basic Weighted Average Shares | 133.9M -31.60% | 195.8M +58.66% | 123.4M +100.57% | 61.5M +193.68% | |
Diluted Weighted Average Shares | 133.9M -31.60% | 195.8M +58.66% | 123.4M +100.57% | 61.5M +193.68% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 108.5M +9.50% | 99.1M +63.43% | 60.6M -87.63% | 490.3M +111,197.47% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 108.5M +9.50% | 99.1M +63.43% | 60.6M -87.63% | 490.3M +111,197.47% | |
Total Current Assets | 280.7M -29.10% | 395.9M +5.81% | 374.1M -25.87% | 504.7M +53,327.68% | |
Accumulated Depreciation | 16.6M +50.04% | 11.0M +44.36% | 7.6M +62.32% | 4.7M N/A | |
Property and Plant and Equipment and Net | 51.2M +21.34% | 42.2M +0.19% | 42.1M +293.57% | 10.7M N/A | |
Total Long-Term Assets | 212.7M -29.42% | 301.4M -12.50% | 344.4M +3,116.70% | 10.7M -95.72% | |
Total Assets | 335.6M -23.92% | 441.1M +4.88% | 420.6M -18.81% | 518.0M +106.21% | |
Income Taxes Payable | 1.1M -24.90% | 1.4M -29.90% | 2.0M +633.81% | 278,000 N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 30.7M -15.12% | 36.2M +44.65% | 25.0M +130.28% | 10.9M +478.41% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 6.9M +24.21% | 5.5M -28.82% | 7.8M +85.98% | 4.2M -45.79% | |
Total Liabilities | 34.8M -11.80% | 39.4M +34.98% | 29.2M +123.76% | 13.1M +36.30% | |
Retained Earnings | -1.3B +5.74% | -1.2B +5.37% | -1.1B +3.22% | -1.1B +13,062.56% | |
Total Stockholders Equity | -1.0B +1.63% | -995.0M -9.83% | -1.1B +0.62% | -1.1B +12,974.22% | |
Total Shares Outstanding | 141.8M -68.86% | 455.4M +99.60% | 228.2M -2.12% | 233.1M +3,283.43% | |
Cash Flow | |||||
Cash from Operating Activities | -120.1M -4.93% | -126.4M +40.28% | -90.1M +16.84% | -77.1M +6,271.80% | |
Capital Expenditures | 15.2M -48.50% | 29.5M -13.71% | 34.2M +1,752.49% | 1.8M N/A | |
Cash from Investing Activities | 104.0M +409.28% | 20.4M +106.19% | -330.0M +18,886.36% | -1.7M -99.30% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 25.6M -82.29% | 144.4M +1,611.97% | -9.6M -101.74% | 548.5M +117.97% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -18,477.83% -92.35% | -241,678.95% N/A | N/A N/A | N/A N/A | |
Return on Assets | -17.77% +25.08% | -14.20% +87.91% | -7.56% -80.38% | -38.52% N/A | |
Return on Equity | 6.88% +17.93% | 5.83% +80.87% | 3.22% -87.97% | 26.81% N/A | |
Revenue Growth | 1,075.00% N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 9.13 -16.47% | 10.93 -26.85% | 14.94 -67.81% | 46.42 N/A | |
Cash Ratio | 3.53 +29.00% | 2.74 +12.98% | 2.42 -94.63% | 45.09 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow